Seeing Is Believing
Healthcare - Sector
ESPR is currently covered by 5 analysts with an average price target of $15.45. This is a potential upside of $12.41 (408.22%) from yesterday's end of day stock price of $3.04.
Esperion Therapeutics's activity chart (see below) currently has 241 price targets and 205 ratings on display. The stock rating distribution of ESPR is 90.91% BUY and 9.09% HOLD.
Analysts average stock forecasts to be materialized ratio is 43.29% with an average time for these price targets to be met of 117.75 days.
Highest price target for ESPR is $4, Lowest price target is $3, average price target is $3.75.
Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 18-Sep-2025.
Currently out of the existing stock ratings of ESPR, 20 are a BUY (90.91%), 2 are a HOLD (9.09%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
1 months 10 days ago
(18-Sep-2025)
0/2 (0%)
$16.92 (333.07%)
Buy
$4
$1.29 (47.60%)
5 months 22 days ago
(06-May-2025)
0/12 (0%)
$3.13 (359.77%)
Hold
$3
$0.29 (10.70%)
$4
6 months 12 days ago
(16-Apr-2025)
9/10 (90%)
$2.05 (215.79%)
89
Buy
$4
$1.29 (47.60%)
7 months 24 days ago
(04-Mar-2025)
1/12 (8.33%)
$2.35 (142.42%)
255
Buy
$4
$1.29 (47.60%)
$7
8 months 18 days ago
(10-Feb-2025)
0/3 (0%)
$2.21 (123.46%)
What is ESPR (Esperion Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on ESPR (Esperion Therapeutics) with a proven track record?
Which analyst has the most public recommendations on ESPR (Esperion Therapeutics)?
Which analyst is the currently most bullish on ESPR (Esperion Therapeutics)?
Which analyst is the currently most reserved on ESPR (Esperion Therapeutics)?